12:00 AM
Jun 30, 2014
 |  BC Week In Review  |  Company News  |  Management Tracks

ThromboGenics management update

ThromboGenics N.V. (Euronext:THR), Leuven, Belgium
Business: Cardiovascular, Ophthalmic...

Read the full 17 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >